NASDAQ:PCSA Heatwurx Q2 2026 Earnings Results & Report $1.56 -0.13 (-7.69%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$1.56 -0.01 (-0.32%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Heatwurx missed analyst earnings expectations in its Q2 2026 results, released August 14, 2026. The company reported EPS of -$1.19 versus the -$1.00 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 14, 2026TimeBefore Market OpensConference Call7:00 AM ET Heatwurx EPS ResultsActual EPS-$1.19Consensus EPS -$1.00Beat/MissMissed by -$0.19One Year Ago EPSN/AEPS Beat Rate3 of last 8 quartersHeatwurx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Heatwurx Q2 2026 Earnings FAQ Did Heatwurx beat earnings estimates for Q2 2026? Heatwurx (NASDAQ:PCSA) reported earnings of -$1.19 per share for Q2 2026, missing the consensus estimate of -$1.00. The report was announced on Friday, August 14, 2026. Heatwurx Earnings HeadlinesProcessa Pharmaceuticals to Participate in Upcoming Investor ConferencesNovember 5, 2026 | globenewswire.comProcessa Pharmaceuticals Announces Key Leadership AppointmentsNovember 4, 2026 | globenewswire.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th. | Behind the Markets (Ad)Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya TherapeuticsOctober 29, 2026 | globenewswire.comProcessa Pharmaceuticals to Participate in Upcoming Investor ConferencesSeptember 1, 2026 | globenewswire.comProcessa Pharmaceuticals, Inc. (PCSA) M&A Call Prepared Remarks TranscriptJuly 29, 2026 | seekingalpha.comSee More Heatwurx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Heatwurx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heatwurx and other key companies, straight to your email. Email Address About HeatwurxHeatwurx (NASDAQ:PCSA) was an asphalt pavement repair technology company. It developed infrared-based equipment and repair methods intended to heat and reuse existing pavement, serving the road and pavement maintenance industry. Heatwurx is a historical company name associated with the business now identified by Nasdaq ticker PCSA. The public company operates as Processa Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious medical conditions.View Heatwurx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.